New developments in early detection and prevention of tumors: molecular tests, artificial intelligence, vaccines, and more

In modern oncology, there is a paradigm shift from treating advanced stages to preventive cancer detection. Despite the success of classical screening, the need for highly sensitive and minimally invasive early diagnostic methods remains critical. The integration of molecular tests and AI algorithms is at the core of this approach. The implementation of these technologies in clinical practice has the potential to reduce mortality by detecting tumors at an early stage. However, issues related to data standardization and economic accessibility remain significant barriers.